Andrew Kidd
Geen lopende functies
Vermogen: 9 700 $ op 31-12-2023
Profiel
Andrew Kidd is former CEO, Chief Financial & Accounting Officer at Aptinyx, Inc. and former Vice President-Strategy & Business Development at Baxter International, Inc. and former General Manager at Baxter Corp.
(a subsidiary of Baxter International, Inc.).
He received an undergraduate degree from the University of Oxford and an undergraduate degree from the University of Cambridge.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
APTINYX INC
0.15% | 24-04-2023 | 101 043 ( 0.15% ) | 9 700 $ | 31-12-2023 |
Eerdere bekende functies van Andrew Kidd
Bedrijven | Functie | Einde |
---|---|---|
APTINYX | Chief Executive Officer | 30-06-2023 |
Baxter Corp.
Baxter Corp. Medical SpecialtiesHealth Technology Baxter Corp. supplies health care and laboratory products. Its products are used for treating cancer, hemophilia, immune deficiencies, kidney disease, and trauma. The company is headquartered in Mississauga, Canada | Corporate Officer/Principal | - |
BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | - |
Opleiding van Andrew Kidd
University of Oxford | Undergraduate Degree |
University of Cambridge | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
BAXTER INTERNATIONAL INC. | Health Technology |
APTINYX | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Baxter Corp.
Baxter Corp. Medical SpecialtiesHealth Technology Baxter Corp. supplies health care and laboratory products. Its products are used for treating cancer, hemophilia, immune deficiencies, kidney disease, and trauma. The company is headquartered in Mississauga, Canada | Health Technology |